Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Latest News about Janet Woodcock
Recent news which mentions Janet Woodcock
Could Marijuana Be A Schedule III Substance? Ex-FDA Official Thinks So
August 28, 2023
Tickers
CCC
CSA
Tags
CCC
Benzinga
Markets
From
Benzinga
Oreo Copycat 'Stoneos' Told To Cease And Desist As FTC Cracks Down On THC Edibles
July 05, 2023
Tags
Nikte's Wholesale LLC
Regulations
Janet Woodcock
From
Benzinga
House Committee To Investigate FDA Inaction On CBD Regulation, GOP Chair Warns About Dangers
April 19, 2023
Tags
News
Top Stories
Cannabis
From
Benzinga
FDA Funds Cannabis Study; NIDA Confirms 5 Entities Seek $25M Contract To Supply Research Weed
April 03, 2023
Tags
NIDA cannabis
News
Cannabis Wire
From
Benzinga
FDA Says Foods & Supplements Regulations Not Appropriate For CBD, Will Work With Congress To Change Them
January 26, 2023
Tickers
CBD
Tags
News
Janet Woodcock
Cannabis
From
Benzinga
FDA Issues Final Clinical Research Guidance For Cannabis, Here Are The Agency's Recommendations
January 23, 2023
Tags
Market News
Politics
Cannabis Research
From
Benzinga
FDA Considers Regulating CBD In Foods & Supplements, Plans To Study Pregnancy And Daily Use
December 27, 2022
Tags
marijuana
Morgan Griffith
Janet Woodcock
From
Benzinga
Top FDA Official Says Marijuana Scheduling Review Is 'A Very High Priority,' But Who Has Final Say?
October 28, 2022
Tickers
HHS
Tags
General
NIDA
Cannabis
From
Benzinga
FDA Finally Advances Cannabis Research & Regulations: Hires Ex-NY Cannabis Policy Regulator
September 28, 2022
Tags
Norman Birenbaum
News
Douglas Throckmorton
From
Benzinga
FDA Issues Warning Letters To Companies Illegally Selling Delta-8 THC, Calls It Dangerous To Consumers
May 04, 2022
Tags
Janet Woodcock
Regulations
Government
From
Benzinga
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.